Ixchelsis Limited   Report issue

For profit Phase 2
Founded: Sandwich United Kingdom (2011)
Status: Defunct (2022)

Organization Overview

First Clinical Trial
2013
NCT01994083
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2017

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (1)

ix-01 (6 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Premature Birth (Phase 2)

Premature Ejaculation (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 6
  • # of Trial APIs: 1